{"product_id":"b0h7f5h3nh","title":"The Brand Plan AI Cannot Write: Brand Strategy and Planning for Pharma and Biotech (Decision-Grade AI Book 4)","description":"\u003cp\u003eYou have been told to use AI more. Nobody has shown you how, not for a brand plan that has to survive medical, legal, and regulatory review, hold up in a payer negotiation, and carry a field force through launch.\u003c\/p\u003e\n\n\u003cp\u003eThis is a strategist's manual, not an introduction to brand planning. It assumes you have built a plan before, and that the judgment about what clears review stays yours.\u003c\/p\u003e\n\n\u003cp\u003eThis is the book that did not exist: a practitioner's guide to using AI correctly for brand strategy and planning in pharma and biotech, written by a pharmacy-trained commercial strategist who holds a BS and MS in Pharmacy and an Executive MBA, with more than thirty years inside US pharma commercial organizations, pressure-tested in draft by industry veterans whose careers span Merck, GSK, Novartis, Genentech, Sanofi, Shire, and Bristol Myers Squibb.\u003c\/p\u003e\n\n\u003cp\u003eAnd it shows the work. Twelve complete, real-world business cases run end to end: field-force sizing, omnichannel and non-personal promotion, competitive early-warning, KOL engagement, and MLR-ready content. Each case moves from setup through the AI workflow to what changed, and then through the implementation reality other books skip: how the work actually clears IT, legal, and medical affairs inside a regulated company, including the enterprise-versus-consumer AI data privacy answer every commercial leader is quietly asking.\u003c\/p\u003e\n\n\u003cp\u003eAI does not write that brand plan. It lets the planner go deeper, faster, and more rigorously into the work brand strategy has always required. This book shows you where the line sits: the thinking AI accelerates, and the judgment it can never replace.\u003c\/p\u003e\n\n\u003cp\u003eAcross thirteen chapters it covers the full arc of pharma and biotech brand planning: situation analysis, patient and physician insight, positioning and strategic imperatives, launch readiness, channel strategy, content, measurement, competitive response, inline growth, and loss of exclusivity. Strategy gets its own chapter rather than a paragraph, including a positioning statement sharp enough to hold a field force, three to five strategic imperatives instead of a twenty-item wish list, and a four-question test for knowing when a strategy is real rather than a slide.\u003c\/p\u003e\n\n\u003cp\u003eEvery chapter hands you tools rather than ideas: a Before-AI and After-AI comparison, field-tested prompts you can run the same day, a framework diagram that anchors the chapter's core decision, and new in this edition, a Best Practices exhibit that distills the chapter to what you should actually do. The foundations open with two exhibits of their own: one that separates strategy from planning, and one that separates data from insight, the difference between what a customer did and why they did it.\u003c\/p\u003e\n\n\u003cp\u003eEvery edition includes the complete companion collection of every prompt in the book, delivered as a PDF. Details are inside the book.\u003c\/p\u003e\n\n\u003cp\u003eGeeta Padbidri's thirty years span brand, marketing, and analytics leadership at Genentech, Pfizer, Bayer, and Otsuka.\u003c\/p\u003e\n\n\u003cp\u003eIt is written for brand leads, product managers, and commercial teams in pharma and biotech.\u003c\/p\u003e\n\n\u003cp\u003eIf your brand plan is due and the guidance never came, start here.\u003c\/p\u003e","brand":"ANT","offers":[{"title":"Ebook","offer_id":67924458668277,"sku":"YSL52416","price":7.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/8774\/8597\/files\/61oer42RrgL._SY1500.jpg?v=1793672905","url":"https:\/\/www.newbooks.store\/products\/b0h7f5h3nh","provider":"NewBooks","version":"1.0","type":"link"}